Health

More news - Breaking news Ann Lurie, a former pediatric nurse turned prominent Chicago philanthropist, died Monday at her home. She was 79. Northwestern University, where Lurie was a trustee and major donor, announced her death without giving a cause. Raised in Miami by a single mother, Lurie was an only child and protested the Vietnam War during her college years. She initially planned to join the Peace Corps, but instead married Robert H. Lurie. Robert Lurie built a large real estate and investment business with Sam Zell, which included holdings such as The Chicago Tribune and the Chicago Cubs. He also invested in sports teams such as the Chicago Bulls and the White Sox. Robert Lurie died of colon cancer in 1990, leaving behind an estate valued at $425 million. Ann Lurie, who event...

More news - Recent news When I was little, my father, who rarely traveled, would tell stories about a trip to Europe he took with his parents at age 14, in 1966. He remembered how Nonie loved the pristine Swiss roads and flowerbeds; the cozy fireplace in the hillside house near Lugano, where her father was born, with its clever alcoves for drying clothes or warming bread; and the palpable poverty in the house in Pozzuoli, near Naples, where Nonie’s aunt lined the walls with newspaper for insulation. Occasionally, my father would show me his Kodachrome slides on a projector. As an adult, I often suggested that we repeat the trip, or at least visit Switzerland and Italy, so he could show me his family roots. But as his Alzheimer’s disease progressed, the idea took on a new urg...

Related media - News 24 hours Countries with limited budgets usually choose to pay for health services considered more essential, such as vaccines, rather than reproductive health, said Dr. Ayman Abdelmohsen, head of the family planning branch of UNFPA's technical division, because they produce more immediate results. return. But a recent push by UNFPA for low-income countries to shoulder more of the costs has led 44 governments to sign up to a new funding model that commits them to increasing their contributions to reproductive health every year. Despite this, there was a significant global shortfall of approximately $95 million in product purchases last year. Donors currently pay for most products, but their funding for 2022 was nearly 15% lower than in 2019, as the climate crisi...

More news - Breaking news Mosquito-borne dengue fever is spreading rapidly around the world, reaching record levels and even popping up in unexpected places. The Centers for Disease Control and Prevention (CDC) is warning doctors in the United States to be on the lookout for cases, as the risk of infection has increased this year. Why the surge? Several factors are driving the rise of dengue. The Aedes a Egypti mosquito, which transmits the virus, thrives in warm, humid environments. Climate change is creating ideal conditions for these mosquitoes to expand their range and become more numerous. Additionally, urbanization is bringing people closer to mosquito breeding grounds, increasing the chances of being bitten. A global problem While tropical countries like Brazil have long battl...

Related media - Breaking news For many Americans, the rising tide of prescription drug prices seems like a relentless force, threatening to swamp family budgets and access to health care. While pharmaceutical companies often assume public responsibility, the web of influences on drug costs is much more intricate. Today we shine our spotlight on a critical, but typically hidden, player in this system: pharmacy benefit managers, or PBMs. Rebecca Robbins, a leading investigative journalist specializing in pharmaceuticals for the New York Times, will take us on a deep dive into the world of PBMs. We will explore their role as intermediaries between drug manufacturers, insurers, pharmacies and, ultimately, patients. This complex dance can have a significant impact on ho...

More news - News 24 hours What is the framework for approval? In 2017, the FDA granted “breakthrough” status to MDMA-assisted therapy. Status, the recognition of a drug's therapeutic promise, aims to shorten regulatory times. The original application was sponsored by the nonprofit Multidisciplinary Association for Psychedelic Studies, which earlier this year created a for-profit entity, Lykos Therapeutics, to commercialize MDMA if it gained approval. FDA approval. The request presents an unusual challenge for the FDA, which typically does not regulate drug treatments associated with talk therapy, an essential part of Lykos' regimen for treating post-traumatic stress disorder. On June 4, an expert advisory panel will review Lykos' clinical data, along with public comments and staff ...